Avaliação histopatológica do efeito do canabidiol em um modelo experimental de carcinogênese oral

Abstract

A late diagnosis of oral squamous cell carcinoma is related to high morbidity and mortality rates, as well as recurrence after treatment. Hence, there is an increasing interest in the validation of biological markers, chemoprevention strategies, and adjuvant treatment alternatives for combating oral cancer. The present Thesis evaluated the anticancer effect of cannabidiol (CBD) in a validated experimental murine model of oral carcinogenesis. Fifteen Fischer 344 rats were randomly divided into three groups of five animals each and subjected to a 7,12-dimethylbenzanthracene (DMBA) topical application on the ventral mucosa of their tongues, thrice a week. From the 2nd to the 12th week, they received intraperitoneally-administered vehicle (group 1), CBD 5 mg/kg (group 2), or CBD 10 mg/kg (group 3). After euthanasia, the tongues were dissected, processed and assessed by histological and immunohistochemical analysis. Group 2 and group 3 showed inhibition of severe oral epithelial dysplasia and carcinoma, and exhibited lower cell proliferation as compared to group 1. The null hypothesis was rejected when results showed statistical significance at a 0.05 level (confidence interval = 95%). In sequence are presented three manuscripts, first one regarding the original experiment and the two subsequent ones providing overall theoretical support.